[Oral contraceptives: APF takes a position].
D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D019049:Developed Countries; D004194:Disease; D004617:Embolism; D005060:Europe; D005193:Family Planning Services; D007390:International Agencies; D009938:Organizations; D011174:Portugal; D045167:Progesterone Congeners; D012307:Risk Factors; D013923:Thromboembolism; D006113:United Kingdom; D014480:United Nations; D014652:Vascular Diseases; D014944:World Health Organization
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D045167:Progesterone Congeners
Biology; Contraception; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Methods--side effects; Developed Countries; Diseases; Embolism; Europe; Family Planning; International Agencies; Nongovernmental Organizations; Northern Europe; Oral Contraceptives, Combined--side effects; Oral Contraceptives--side effects; Organizations; Portugal; Progestins, Low-dose--side effects; Risk Factors; Southern Europe; Thromboembolism; Un; United Kingdom; Vascular Diseases; Who